Literature DB >> 6519203

A role for glutathione and glutathione reductase in control of corneal hydration.

M V Riley.   

Abstract

We have assessed the importance of the glutathione redox system of the corneal endothelial cells in the control of stromal hydration. The ability of freshly isolated corneas to maintain normal hydration during perfusion, while the activity of glutathione reductase was inhibited with 1.3-bis(2-chloroethyl)-1-nitrosourea (BCNU), was tested under a number of conditions. BCNU at 125 microM led to mild swelling and at 500 microM to more severe swelling. Swelling was also severe when 50 microM H2O2 was added together with 125 microM BCNU. The concentration of total glutathione (GSH + GSSG) in the endothelia of these corneas was decreased and the fraction found in the oxidized form was higher than in controls without BCNU. Glutathione reductase activity was inhibited in the perfused endothelia by 90%. With the addition of 0.5 mM GSSG during perfusion, swelling due to 125 microM BCNU was at a slightly lower rate and reductase activity was inhibited only 79%. Complete protection was afforded against 125 microM BCNU induced swelling by 1.0 mM GSH, corneas maintaining normal thickness for over 4 hr. The endothelial surface of the perfused corneas was shown by scanning electron microscopy to be little disturbed by the low concentration of BCNU, but at high concentration, or with H2O2 added, the cells were collapsed and had a heavily pitted appearance. We conclude that when the cornea is under oxidative stress (e.g. in the presence of H2O2) a rapid turnover of endothelial GSH via glutathione reductase and the hexose monophosphate shunt is required. Under conditions of less stress, the reduced need for GSH to counteract oxidative threats can be supplied either exogenously or by the partially inhibited reductase.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6519203     DOI: 10.1016/0014-4835(84)90074-5

Source DB:  PubMed          Journal:  Exp Eye Res        ISSN: 0014-4835            Impact factor:   3.467


  8 in total

Review 1.  Focus on molecular events in the anterior chamber leading to glaucoma.

Authors:  Sergio Claudio Saccà; Alberto Izzotti
Journal:  Cell Mol Life Sci       Date:  2013-10-19       Impact factor: 9.261

2.  Intraocular irrigating solutions and barrier function of retinal pigment epithelium.

Authors:  M Araie; M Kimura
Journal:  Br J Ophthalmol       Date:  1997-02       Impact factor: 4.638

Review 3.  Ultraviolet radiation: cellular antioxidant response and the role of ocular aldehyde dehydrogenase enzymes.

Authors:  Satori A Marchitti; Ying Chen; David C Thompson; Vasilis Vasiliou
Journal:  Eye Contact Lens       Date:  2011-07       Impact factor: 2.018

4.  Morphology of the pig cornea in normal conditions and after incubation in a perfusion apparatus.

Authors:  O Camber; C Rehbinder; T Nikkila; P Edman
Journal:  Acta Vet Scand       Date:  1987       Impact factor: 1.695

5.  Hydrolases of anterior segment tissues in the normal human, pig and rat eye: a comparative study.

Authors:  S E Coupland; P L Penfold; F A Billson
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1994-03       Impact factor: 3.117

Review 6.  Antioxidant defenses in the ocular surface.

Authors:  Ying Chen; Gaurav Mehta; Vasilis Vasiliou
Journal:  Ocul Surf       Date:  2009-10       Impact factor: 5.033

7.  Dehydroascorbate influences the plant cell cycle through a glutathione-independent reduction mechanism.

Authors:  Geert Potters; Nele Horemans; Silvia Bellone; Roland J Caubergs; Paolo Trost; Yves Guisez; Han Asard
Journal:  Plant Physiol       Date:  2004-03-26       Impact factor: 8.340

8.  Mitochondria-Targeted Antioxidant SkQ1 Prevents Anesthesia-Induced Dry Eye Syndrome.

Authors:  Evgeni Yu Zernii; Olga S Gancharova; Viktoriia E Baksheeva; Marina O Golovastova; Ekaterina I Kabanova; Marina S Savchenko; Veronika V Tiulina; Larisa F Sotnikova; Andrey A Zamyatnin; Pavel P Philippov; Ivan I Senin
Journal:  Oxid Med Cell Longev       Date:  2017-10-12       Impact factor: 6.543

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.